Alemtuzumab Treatment Leads to Delayed Recovery of T Follicular Regulatory Cells, and May Therefore Predispose Patients to de novo Donor-Specific Antibody Formation (2019)
Attributed to:
The Role of Follicular T Cells in the Alloimmune Response and Alloantibody Formation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.21926/obm.transplant.1903079
Publication URI: http://dx.doi.org/10.21926/obm.transplant.1903079
Type: Journal Article/Review
Parent Publication: OBM Transplantation
Issue: 3